Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vanda Pharmaceuticals

4.69
+0.09001.96%
Post-market: 4.56-0.1299-2.77%17:01 EDT
Volume:735.09K
Turnover:3.42M
Market Cap:273.50M
PE:-14.21
High:4.71
Open:4.62
Low:4.57
Close:4.60
Loading ...
Feb 24, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Major Issues Report

8-K - Current report
Jan 14, 2022

Major Issues Report

8-K - Current report
Dec 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 17, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 13, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 23, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 17, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 30, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 29, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 28, 2021

Major Issues Report

8-K - Current report
Jun 10, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans